Preterm Birth Control Industry rise to CAGR of 4.9 % from 2022 to 2025

Posted by kartik joshi on September 28th, 2022

Preterm birth control market is slated to amass US$ US$ 1,809.0 million by 2025 from US$ 1,190.5 million in 2017, expanding at 4.9% CAGR from 2018 to 2025. Increasing number of preterm births and initiatives to prevent preterm births are the key factors contributing to market expansion.

There has been a gradual increase in the number of preterm births from last few years. It may be due to early induction of labor or caesarean birth. Multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure are others common causes of preterm births. As per the Centers for Disease Control and Prevention (CDC), reduction in preterm birth was observed from 2007 to 2014. In 2015, low birth weight and preterm birth accounted for about 17% of infant deaths. However, the number increased during 2016, with racial and ethnic differences. In the US, 1 in every 10 infants born was a preterm birth.

Sample Report Copy from Here

https://www.theinsightpartners.com/sample/TIPMD00002026/

A number of government and non-government organizations are engaged in increasing awareness of preterm birth in various countries across the globe. Organizations such as CDC has implemented strategies to reduce preterm births. These strategies includes provision of healthcare services before and between pregnancies; determining population at the risk of preterm delivery and provide immediate treatment, discouraging deliveries before 39 weeks without a medical need; and preventing unintended pregnancies by waiting for at least 18 months between pregnancies.

The WHO is also working toward creating awareness about preterm birth control to provide care to premature babies and prevent preterm births. Kangaroo Mother Care and WHO Antenatal Care Guidelines are two important strategic initiatives. WHO Antenatal Care Guidelines provide information on and recommend key interventions to prevent pre-term birth including nutrition guidelines, introduction of ultrasound scans and increasing contacts with healthcare professionals in case of an emergency. On the other hand, the stringent regulatory framework is hindering market expansion.

Based on treatment method, the global preterm birth control market is divided into pharmaceutical treatment and devices. Among these, the pharmaceutical treatment segment accounted for 55.6% of the market share in 2017. The segment was evaluated at US$ 661.9 million in 2017 and is anticipated to reach US$ 1,041.9 million by 2025, growing at 6.1% CAGR during the forecast period.

Regionally speaking, North America held a significant share in the global preterm birth control market in 2017. The regional market was assessed at US$ 448.1 million in 2017 and is estimated to garner US$ 718.2 million by 2025, expanding at a stellar growth rate of 6.3% between 2017 and 2025.

Leading players formulating the competitive landscape of the global preterm birth control market are CooperSurgical, Inc.; MedGyn Products, Inc.; Integra LifeSciences Corporation; Panpac Medical Corporation; Dr. Arabin GmbH & Co. KG; AMAG Pharmaceuticals, Inc.; Ben Way Enterprises Sdn. Bhd.; Personal Medical Corporation; Bioteque America, Inc.; and Bliss GVS Pharma Limited.

Contact Us

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com